Europe's rich heritage in pharmaceutical innovation has significantly shaped the global landscape. Yet, recent decades have seen this continent cede its leading position to the U.S. and witness emerging markets like China and India surge ahead. The question now is whether Europe can chart a path
In a significant move within the life sciences industry, Cryoport, Inc. and SK pharmteco have announced a strategic partnership focused on advancing cell and gene therapy. This collaboration aims to integrate logistics and manufacturing services for biotechnology and pharmaceutical companies,
Sutro Biopharma Inc. (NASDAQ: STRO) has experienced a dynamic market journey characterized by several key financial metrics, analyst ratings, and insider transactions. This article delves into the company’s recent market performance, aiming to provide investors with a comprehensive understanding of
The global biopharmaceutical contract manufacturing market is anticipated to experience significant growth from 2024 to 2032. This market's expansion is driven by continuous technological innovations, increased research and development (R&D) investments, and strategic collaborations among key
The biotech sector is brimming with opportunities that extend far beyond the much-talked-about GLP-1 weight-loss drugs, which have garnered significant attention following the 2024 European Association for the Study of Diabetes (EASD) meeting. While GLP-1 treatments, led by giants like Eli Lilly
The biopharma sector has experienced a roller coaster of venture capital investments over the past decade and a half. From explosive growth driven by the COVID-19 pandemic to a more selective and strategic investment environment, the landscape continues to evolve rapidly. This article will delve
